Posted on 18/10/2024
Our Annual Review Meeting took place on 1 October at the TOPRA Symposium 2024 in Rotterdam, and was presented by current TOPRA President Michael Kipping.
Posted on 03/10/2024
The 2023 recipients of formal recognition for their valued contributions to TOPRA and the regulatory affairs profession were announced at the Annual Review Meeting held on 24 October at the TOPRA Symposium 2023 in Lisbon.
Posted on 03/10/2024
Results of the elections to the TOPRA Board of Directors were announced at the Annual Review Meeting held on 1 October at the TOPRA Symposium 2024 in Rotterdam.
Posted on 27/09/2024
Victoria Goff has been announced as the new Editor-in-Chief of Regulatory Rapporteur, TOPRA’s respected international journal.
Posted on 17/07/2024
TOPRA has been confirmed as an Association Partner for AfriSummit for a second year running. Taking place on 3-6 November 2024 in Cairo, Egypt.
Posted on 08/07/2024
Easy on-the-go access to our online resources is a priority for our members, which is why we have revised and relaunched our app for 2024.
Posted on 23/05/2024
As the leading membership body for healthcare regulatory affairs, our ambition is that TOPRA continues to be vibrant and relevant for our international community.
Posted on 22/05/2024
TOPRA has been confirmed as a supporter of the 13th Annual Global Pharma Regulatory Summit being held by Informa.
Posted on 17/05/2024
Regulatory Rapporteur is TOPRA’s respected online journal, published 11 times per year and available free to TOPRA members.
Posted on 13/03/2024
TOPRA’s volunteers play a vital role in enabling us to support our dynamic international community of members.
Posted on 11/03/2024
TOPRA has been confirmed as an Association Partner for the ninth GCC Regulatory Affairs Pharma Summit.
Posted on 02/02/2024
Ofsted has judged TOPRA as ‘Good’ in all areas in its recent full inspection of the training programme for the Level 7 Regulatory Affairs Specialist Apprenticeship.
Posted on 26/01/2024
TOPRA partners with EUPATI to support patient involvement in healthcare regulatory affairs.